Skip to main content

CO-295 Denial Code: Pharmacy Direct/Indirect Remuneration

CO-295 reports a pharmacy Direct/Indirect Remuneration (DIR) adjustment: a price concession or fee tied to a pharmacy's claims that reduces what the pharmacy keeps. It applies to pharmacy claims, mainly in Medicare Part D arrangements, not to medical claims.

Quick facts

Code
CO-295 (CARC 295)
Status
Active In use since March 1, 2018.
Code set
Claim Adjustment Reason Codes (CARC)
Group codes
  • CO (Contractual Obligation): The usual group. The adjustment is a contractual reduction between the pharmacy and the plan or PBM and isn't billed to the patient.
Official description
Pharmacy Direct/Indirect Remuneration (DIR)
X12 Claim Adjustment Reason Codes, retrieved September 25, 2026
Last verified
against the official X12 list.

What CO-295 means

CARC 295 is Pharmacy Direct/Indirect Remuneration (DIR). DIR describes price concessions and fees that change the final amount a pharmacy keeps on a prescription claim after it was paid. In Medicare Part D, DIR has historically included fees assessed on pharmacies under network agreements and performance programs, sometimes months after the prescription was filled.

This code is for pharmacy remittances. It lets a plan or pharmacy benefit manager show, at the claim level, the portion of payment affected by remuneration terms. It isn’t a denial and isn’t patient responsibility.

CMS changed Part D rules so that, beginning in 2024, pharmacy price concessions must be reflected at the point of sale rather than collected retroactively. That reduced the classic “clawback” pattern, but contract terms and reporting practices still vary, so the code can still appear.

Common causes

  • Network agreement fees applied to pharmacy claims.
  • Performance-based adjustments tied to pharmacy quality measures.
  • Reconciliation of prior claims under a pharmacy contract.
  • PBM programs that assess or credit amounts at the claim level.

How to handle it

  1. Match the adjustment to the original claim and its payment.
  2. Check the pharmacy network agreement and any performance program terms for the rate or fee that applies.
  3. Reconcile the net payment per claim to know the true reimbursement for each drug.
  4. Dispute discrepancies with the PBM or plan using the contract’s dispute process.
  5. Don’t bill the patient for DIR adjustments.

How to prevent problems

  • Model expected net reimbursement for each contract, including fees and concessions.
  • Monitor performance metrics that affect adjustments.
  • Review contracts for how remuneration is calculated and reported.
  • Track CO-295 totals by payer so trends are visible. An ERA Analyzer can separate these lines from other adjustments.

Specialty notes

Retail, specialty, and long-term care pharmacies are the only providers that typically encounter CO-295. Independent pharmacies often rely on a pharmacy services administrative organization for contract terms, so coordinate reconciliation with it.

Remark codes that may appear with CO-295

  • N381 (Alert: Consult our contractual agreement for restrictions/billing/payment information related to these charges.): Points to the contract that defines the remuneration terms.
  • CO-90 (Ingredient cost adjustment.): Ingredient cost adjustment on a pharmacy claim.
  • CO-91 (Dispensing fee adjustment.): Dispensing fee adjustment on a pharmacy claim.
  • CO-205 (Pharmacy discount card processing fee): Pharmacy discount card processing fee.
  • CO-144 (Incentive adjustment, e.g. preferred product/service.): Incentive adjustment, such as for a preferred product or service.
  • CO-45 (Charge exceeds fee schedule/maximum allowable or contracted/legislated fee arrangement.): The general contractual reduction used on medical claims.

CO-295 FAQ

What is DIR?

Direct and indirect remuneration is a Medicare Part D term for price concessions and other payments that change the final cost of a drug after the point of sale, such as pharmacy performance fees or network fees.

Does CO-295 apply to physician practices?

No. It relates to pharmacy claims and pharmacy contracts with plans and pharmacy benefit managers. Medical practices billing drugs on professional claims shouldn't see it.

How should a pharmacy reconcile CO-295?

Compare the adjustment to the pharmacy's network agreement and any performance program terms. Reconcile it against the original claim's payment and track the net amount per claim.

Have DIR rules changed?

Yes. CMS changed the Part D rules so that, starting in 2024, pharmacy price concessions must be reflected in the negotiated price at the point of sale. How remaining adjustments are reported varies, so check your contracts and PBM communications.

Is CO-295 a denial?

No. The prescription claim was processed. CO-295 shows a remuneration adjustment that changes the pharmacy's net payment.